Quellis Biosciences is an emerging biopharmaceutical company focused on discovering best-in-class new molecules.
Quellis Biosciences is dedicated to improving the lives of patients suffering from serious rare diseases by developing next-generation antibody therapies that deliver value by improving patient outcomes.Quellis was founded to deliver best-in-class therapies to patients suffering serious rare diseases – and underserved by current treatment options.